Strategizing for Regulatory Approval when Designing Clinical Trials for Neurological Gene Therapies

Time: 3:30 pm
day: Conference Day Two


  • Understanding how to set up your clinical trial design to please regulators
  • Identifying novel biomarkers to CNS indications to utilize in clinical monitoring
  • Accelerating clinical studies with endpoints to show disease modifying effects at a faster rate